Trevena (NASDAQ:TRVN) Shares Pass Below 200 Day Moving Average – Here’s Why

Trevena, Inc. (NASDAQ:TRVN)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.14 and traded as low as $1.26. Trevena shares last traded at $1.28, with a volume of 1,018 shares traded.

Wall Street Analysts Forecast Growth

Separately, StockNews.com started coverage on Trevena in a research report on Thursday. They issued a “sell” rating for the company.

Trevena Trading Down 7.9 %

The stock has a fifty day simple moving average of $1.62 and a two-hundred day simple moving average of $2.14. The firm has a market cap of $1.11 million, a PE ratio of -0.03 and a beta of 1.05.

About Trevena

Trevena, Inc, a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain.